14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PYC.AX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Phylogica Limited stock price ended at $0.110 on Monday, after gaining 4.76%.
(Updated on Jun 17, 2024)

Buy candidate since Jun 13, 2024 Gain 4.76% PDF

The Phylogica Limited stock price gained 4.76% on the last trading day (Monday, 17th Jun 2024), rising from $0.105 to $0.110. During the last trading day the stock fluctuated 7.84% from a day low at $0.102 to a day high of $0.110. The price has been going up and down for this period, and there has been a 4.76% gain for the last 2 weeks. Volume fell on the last day by -734 thousand shares and in total, 1 million shares were bought and sold for approximately $118.19 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 27.06% during the next 3 months and, with a 90% probability hold a price between $0.129 and $0.161 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PYC.AX Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Friday, May 24, 2024, and so far it has fallen -8.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The Phylogica Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.105 and $0.104. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Phylogica Limited stock

Phylogica Limited finds support from accumulated volume at $0.105 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0080 between high and low, or 7.84%. For the last week the stock has had daily average volatility of 7.09%.

Our recommended stop-loss: $0.105 (-4.23%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 16 days ago.)

Trading Expectations (PYC.AX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Phylogica Limited to open at $0.107, and during the day (based on 14 day Average True Range), to move between $0.102 and $0.118, which gives a possible trading interval of +/-$0.0079 (+/-7.15%) up or down from last closing price. If Phylogica Limited takes out the full calculated possible swing range there will be an estimated 14.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.115 (4.55%) than the support at $0.105 (4.55%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Phylogica Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Phylogica Limited stock to perform well in the short-term.

Current score: 3.047 Buy Candidate Unchanged

Predicted Opening Price for Phylogica Limited of Tuesday, June 18, 2024

Fair opening price June 18, 2024 Current price
$0.107 ( 2.42%) $0.110

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PYC.AX

Fibonacci Support & Resistance Levels

Level Price
R3 0.115 4.85%
R2 0.112 2.07%
R1 0.110 0.354%
Price 0.110
S1 0.104 -5.20%
S2 0.102 -6.92%
S3 0.0993 -9.70%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0.120 9.09%
R1 0.115 4.55%
Price 0.110
S1 0.105 -4.55%
S2 0.100 -9.09%
S3 0.0970 -11.82%

FAQ

What is the symbol for Phylogica Limited Stock and on which exchange is it traded?
The symbol for Phylogica Limited is PYC.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Phylogica Limited Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Phylogica Limited stock to perform well in the short-term.

How to buy Phylogica Limited Stock?
Phylogica Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Phylogica Limited Stock.

What's the current price of Phylogica Limited Stock?
As of the end of day on the Jun 17, 2024, the price of an Phylogica Limited (PYC.AX) share was $0.110.

What is the 52-week high and low for Phylogica Limited Stock?
The 52-week high for Phylogica Limited Stock is $0.125 and the 52-week low is $0.0520.

What is the market capitalization of Phylogica Limited Stock?
As of the Jun 17, 2024, the market capitalization of Phylogica Limited is 513.269M.

When is the next earnings date for Phylogica Limited?
The upcoming earnings date for Phylogica Limited is Jul 24, 2024.
Click to get the best stock tips daily for free!

About Phylogica Limited

Phylogica Limited PYC Therapeutics Limited, a development-stage biotechnology company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and VP-002, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for retinal and central... PYC.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT